O	0	8	Dopamine	Dopamine	NN	B-NP
O	9	18	regulates	regulate	VBZ	B-VP
O	19	34	phosphorylation	phosphorylation	NN	B-NP
O	35	37	of	of	IN	B-PP
O	38	42	VEGF	VEGF	NN	B-NP
O	43	51	receptor	receptor	NN	I-NP
O	52	53	2	2	CD	I-NP
O	54	56	by	by	IN	B-PP
O	57	65	engaging	engage	VBG	B-VP
O	66	69	Src	Src	NN	B-NP
O	69	70	-	-	HYPH	B-NP
O	70	78	homology	homology	NN	I-NP
O	78	79	-	-	HYPH	B-NP
O	79	80	2	2	CD	I-NP
O	80	81	-	-	HYPH	I-NP
O	81	87	domain	domain	NN	I-NP
O	87	88	-	-	HYPH	O
O	88	98	containing	contain	VBG	B-VP
O	99	106	protein	protein	NN	B-NP
O	107	115	tyrosine	tyrosine	NN	I-NP
O	116	127	phosphatase	phosphatase	NN	I-NP
O	128	129	2	2	CD	I-NP
O	129	130	.	.	.	O

O	131	139	Vascular	Vascular	JJ	B-NP
O	140	151	endothelial	endothelial	JJ	I-NP
O	152	158	growth	growth	NN	I-NP
O	159	165	factor	factor	NN	I-NP
O	166	167	(	(	(	O
O	167	171	VEGF	VEGF	NN	B-NP
O	171	172	)	)	)	O
O	172	173	-	-	HYPH	B-NP
O	173	180	induced	induce	VBN	I-NP
O	181	189	receptor	receptor	NN	I-NP
O	190	205	phosphorylation	phosphorylation	NN	I-NP
O	206	208	is	be	VBZ	B-VP
O	209	212	the	the	DT	B-NP
O	213	220	crucial	crucial	JJ	I-NP
O	221	225	step	step	NN	I-NP
O	226	229	for	for	IN	B-PP
O	230	240	initiating	initiate	VBG	B-VP
O	241	251	downstream	downstream	JJ	B-NP
O	252	261	signaling	signaling	NN	I-NP
O	262	270	pathways	pathway	NNS	I-NP
O	271	275	that	that	WDT	B-NP
O	276	280	lead	lead	VBP	B-VP
O	281	283	to	to	TO	B-PP
O	284	296	angiogenesis	angiogenesis	NN	B-NP
O	297	299	or	or	CC	I-NP
O	300	307	related	related	JJ	I-NP
O	308	326	pathophysiological	pathophysiological	JJ	I-NP
O	327	335	outcomes	outcome	NNS	I-NP
O	335	336	.	.	.	O

O	337	340	Our	Our	PRP$	B-NP
O	341	349	previous	previous	JJ	I-NP
O	350	357	studies	study	NNS	I-NP
O	358	362	have	have	VBP	B-VP
O	363	368	shown	show	VBN	I-VP
O	369	373	that	that	IN	B-SBAR
O	374	377	the	the	DT	B-NP
O	378	394	neurotransmitter	neurotransmitter	NN	I-NP
O	395	403	dopamine	dopamine	NN	I-NP
O	404	409	could	could	MD	B-VP
O	410	417	inhibit	inhibit	VB	I-VP
O	418	422	VEGF	VEGF	NN	B-NP
O	422	423	-	-	HYPH	B-NP
O	423	430	induced	induce	VBN	I-NP
O	431	446	phosphorylation	phosphorylation	NN	I-NP
O	447	449	of	of	IN	B-PP
O	450	454	VEGF	VEGF	NN	B-NP
O	455	463	receptor	receptor	NN	I-NP
O	464	465	2	2	CD	I-NP
O	466	467	(	(	(	O
O	467	472	VEGFR	VEGFR	NN	B-NP
O	472	473	-	-	HYPH	O
O	473	474	2	2	CD	B-NP
O	474	475	)	)	)	O
O	475	476	,	,	,	O
B-Cell	477	488	endothelial	endothelial	JJ	B-NP
I-Cell	489	493	cell	cell	NN	I-NP
O	494	507	proliferation	proliferation	NN	I-NP
O	507	508	,	,	,	O
O	509	518	migration	migration	NN	B-NP
O	518	519	,	,	,	O
B-Tissue	520	533	microvascular	microvascular	JJ	B-NP
O	534	546	permeability	permeability	NN	I-NP
O	546	547	,	,	,	O
O	548	551	and	and	CC	O
O	552	556	thus	thus	RB	O
O	556	557	,	,	,	O
O	558	570	angiogenesis	angiogenesis	NN	B-NP
O	570	571	.	.	.	O

O	572	574	In	In	IN	B-PP
O	575	579	this	this	DT	B-NP
O	580	585	study	study	NN	I-NP
O	585	586	,	,	,	O
O	587	589	we	we	PRP	B-NP
O	590	597	address	address	VBP	B-VP
O	598	601	the	the	DT	B-NP
O	602	611	mechanism	mechanism	NN	I-NP
O	612	614	by	by	IN	B-PP
O	615	620	which	which	WDT	B-NP
O	621	626	VEGFR	VEGFR	NN	B-NP
O	626	627	-	-	HYPH	I-NP
O	627	628	2	2	CD	I-NP
O	629	644	phosphorylation	phosphorylation	NN	I-NP
O	645	647	is	be	VBZ	B-VP
O	648	657	regulated	regulate	VBN	I-VP
O	658	660	by	by	IN	B-PP
O	661	669	dopamine	dopamine	NN	B-NP
O	669	670	.	.	.	O

O	671	675	Here	Here	RB	B-ADVP
O	675	676	,	,	,	O
O	677	679	we	we	PRP	B-NP
O	680	691	demonstrate	demonstrate	VBP	B-VP
O	692	696	that	that	IN	B-SBAR
O	697	699	D2	D2	NN	B-NP
O	700	708	dopamine	dopamine	NN	I-NP
O	709	717	receptor	receptor	NN	I-NP
O	718	719	(	(	(	O
O	719	723	D2DR	D2DR	NN	B-NP
O	723	724	)	)	)	O
O	725	736	colocalizes	colocalize	VBZ	B-VP
O	737	741	with	with	IN	B-PP
O	742	747	VEGFR	VEGFR	NN	B-NP
O	747	748	-	-	HYPH	B-NP
O	748	749	2	2	CD	I-NP
O	750	752	at	at	IN	B-PP
O	753	756	the	the	DT	B-NP
B-Cellular_component	757	761	cell	cell	NN	I-NP
I-Cellular_component	762	769	surface	surface	NN	I-NP
O	769	770	.	.	.	O

O	771	779	Dopamine	Dopamine	NN	B-NP
O	780	792	pretreatment	pretreatment	NN	I-NP
O	793	802	increases	increase	VBZ	B-VP
O	803	806	the	the	DT	B-NP
O	807	820	translocation	translocation	NN	I-NP
O	821	824	and	and	CC	I-NP
O	825	839	colocalization	colocalization	NN	I-NP
O	840	842	of	of	IN	B-PP
O	843	846	Src	Src	NN	B-NP
O	846	847	-	-	HYPH	B-NP
O	847	855	homology	homology	NN	I-NP
O	855	856	-	-	HYPH	B-NP
O	856	857	2	2	CD	I-NP
O	857	858	-	-	HYPH	I-NP
O	858	864	domain	domain	NN	I-NP
O	864	865	-	-	HYPH	O
O	865	875	containing	contain	VBG	B-VP
O	876	883	protein	protein	NN	B-NP
O	884	892	tyrosine	tyrosine	NN	I-NP
O	893	904	phosphatase	phosphatase	NN	I-NP
O	905	906	(	(	(	O
O	906	909	SHP	SHP	NN	B-NP
O	909	910	-	-	HYPH	O
O	910	911	2	2	CD	B-NP
O	911	912	)	)	)	O
O	913	917	with	with	IN	B-PP
O	918	922	D2DR	D2DR	NN	B-NP
O	923	925	at	at	IN	B-PP
O	926	929	the	the	DT	B-NP
B-Cellular_component	930	934	cell	cell	NN	I-NP
I-Cellular_component	935	942	surface	surface	NN	I-NP
O	942	943	.	.	.	O

O	944	952	Dopamine	Dopamine	NN	B-NP
O	953	967	administration	administration	NN	I-NP
O	968	973	leads	lead	VBZ	B-VP
O	974	976	to	to	TO	B-PP
O	977	986	increased	increase	VBN	B-NP
O	987	991	VEGF	VEGF	NN	I-NP
O	991	992	-	-	HYPH	O
O	992	999	induced	induce	VBN	B-NP
O	1000	1015	phosphorylation	phosphorylation	NN	I-NP
O	1016	1018	of	of	IN	B-PP
O	1019	1022	SHP	SHP	NN	B-NP
O	1022	1023	-	-	HYPH	B-NP
O	1023	1024	2	2	CD	I-NP
O	1025	1028	and	and	CC	O
O	1029	1033	this	this	DT	B-NP
O	1034	1043	increased	increase	VBN	I-NP
O	1044	1059	phosphorylation	phosphorylation	NN	I-NP
O	1060	1069	parallels	parallel	VBZ	B-VP
O	1070	1073	the	the	DT	B-NP
O	1074	1083	increased	increase	VBN	I-NP
O	1084	1095	phosphatase	phosphatase	NN	I-NP
O	1096	1104	activity	activity	NN	I-NP
O	1105	1107	of	of	IN	B-PP
O	1108	1111	SHP	SHP	NN	B-NP
O	1111	1112	-	-	HYPH	B-NP
O	1112	1113	2	2	CD	I-NP
O	1113	1114	.	.	.	O

O	1115	1121	Active	Active	JJ	B-NP
O	1122	1125	SHP	SHP	NN	I-NP
O	1125	1126	-	-	HYPH	O
O	1126	1127	2	2	CD	B-NP
O	1128	1132	then	then	RB	B-ADVP
O	1133	1149	dephosphorylates	dephosphorylate	VBZ	B-VP
O	1150	1155	VEGFR	VEGFR	NN	B-NP
O	1155	1156	-	-	HYPH	O
O	1156	1157	2	2	CD	B-NP
O	1158	1160	at	at	IN	B-PP
O	1161	1165	Y951	Y951	NN	B-NP
O	1165	1166	,	,	,	I-NP
O	1167	1171	Y996	Y996	NN	I-NP
O	1172	1175	and	and	CC	I-NP
O	1176	1181	Y1059	Y1059	NN	I-NP
O	1181	1182	,	,	,	B-NP
O	1183	1186	but	but	CC	I-NP
O	1187	1190	not	not	RB	I-NP
O	1191	1196	Y1175	Y1175	NN	B-NP
O	1196	1197	.	.	.	O

O	1198	1200	We	We	PRP	B-NP
O	1201	1205	also	also	RB	B-ADVP
O	1206	1213	observe	observe	VBP	B-VP
O	1214	1218	that	that	IN	B-SBAR
O	1219	1222	SHP	SHP	NN	B-NP
O	1222	1223	-	-	HYPH	B-NP
O	1223	1224	2	2	CD	I-NP
O	1225	1234	knockdown	knockdown	NN	I-NP
O	1235	1242	impairs	impair	VBZ	B-VP
O	1243	1246	the	the	DT	B-NP
O	1247	1255	dopamine	dopamine	NN	I-NP
O	1255	1256	-	-	HYPH	B-VP
O	1256	1265	regulated	regulate	VBN	B-NP
O	1266	1276	inhibition	inhibition	NN	I-NP
O	1277	1279	of	of	IN	B-PP
O	1280	1284	VEGF	VEGF	NN	B-NP
O	1284	1285	-	-	HYPH	B-NP
O	1285	1292	induced	induce	VBN	I-NP
O	1293	1308	phosphorylation	phosphorylation	NN	I-NP
O	1309	1311	of	of	IN	B-PP
O	1312	1317	VEGFR	VEGFR	NN	B-NP
O	1317	1318	-	-	HYPH	B-NP
O	1318	1319	2	2	CD	I-NP
O	1320	1323	and	and	CC	O
O	1323	1324	,	,	,	O
O	1325	1337	subsequently	subsequently	RB	B-ADVP
O	1337	1338	,	,	,	O
O	1339	1342	Src	Src	NN	B-NP
O	1343	1358	phosphorylation	phosphorylation	NN	I-NP
O	1359	1362	and	and	CC	I-NP
O	1363	1372	migration	migration	NN	I-NP
O	1372	1373	.	.	.	O

O	1374	1377	Our	Our	PRP$	B-NP
O	1378	1382	data	datum	NNS	I-NP
O	1383	1392	establish	establish	VBP	B-VP
O	1393	1394	a	a	DT	B-NP
O	1395	1400	novel	novel	JJ	I-NP
O	1401	1405	role	role	NN	I-NP
O	1406	1409	for	for	IN	B-PP
O	1410	1413	SHP	SHP	NN	B-NP
O	1413	1414	-	-	HYPH	B-NP
O	1414	1415	2	2	CD	I-NP
O	1416	1427	phosphatase	phosphatase	NN	I-NP
O	1428	1430	in	in	IN	B-PP
O	1431	1434	the	the	DT	B-NP
O	1435	1443	dopamine	dopamine	NN	I-NP
O	1443	1444	-	-	HYPH	B-VP
O	1444	1452	mediated	mediate	VBN	B-NP
O	1453	1463	regulation	regulation	NN	I-NP
O	1464	1466	of	of	IN	B-PP
O	1467	1472	VEGFR	VEGFR	NN	B-NP
O	1472	1473	-	-	HYPH	B-NP
O	1473	1474	2	2	CD	I-NP
O	1475	1490	phosphorylation	phosphorylation	NN	I-NP
O	1490	1491	.	.	.	O

